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The Journal of Immunology
B Cell–Intrinsic and –Extrinsic Regulation of Antibody
Responses by PARP14, an Intracellular
(ADP-Ribosyl)Transferase
Sung Hoon Cho,* Ariel Raybuck,* Mei Wei,* John Erickson,*,† Ki Taek Nam,‡
Reagan G. Cox,*,† Alyssa Trochtenberg,* James W. Thomas,*,x John Williams,*,† and
Mark Boothby*,x
The capacity to achieve sufficient concentrations of Ag-specific Ab of the appropriate isotypes is a critical component of immunity
that requires efficient differentiation and interactions of Ag-specific B and Th cells along with dendritic cells. Numerous bacterial
toxins catalyze mono(ADP-ribosyl)ation of mammalian proteins to influence cell physiology and adaptive immunity. However, little
is known about biological functions of intracellular mammalian mono(ADP-ribosyl)transferases, such as any ability to regulate Ab
responses. poly-(ADP-ribose) polymerase 14 (PARP14), an intracellular protein highly expressed in lymphoid cells, binds to STAT6
and encodes a catalytic domain with mammalian mono(ADP-ribosyl)transferase activity. In this article, we show that recall IgA as
well as the STAT6-dependent IgEAb responses are impaired in PARP14-deficient mice.Whereas PARP14 regulation of IgE involved
a B cell–intrinsic process, the predominant impact on IgA was B cell extrinsic. Of note, PARP14 deficiency reduced the levels of
Th17 cells and CD103+ DCs, which are implicated in IgA regulation. PARP14 enhanced the expression of RORa, Runx1, and
Smad3 after T cell activation, and, importantly, its catalytic activity of PARP14 promoted Th17 differentiation. Collectively, the
findings show that PARP14 influences the class distribution, affinity repertoire, and recall capacity of Ab responses in mice, as well
as provide direct evidence of the requirement for protein mono-ADP-ribosylation in Th cell differentiation. The Journal of
Immunology, 2013, 191: 3169–3178.
A
daptive immunity depends on the level and effector
functions of specific Th cell subsets and the Ab classes
and affinities generated as a consequence of antigenic
challenge. Moreover, these features are determinants of vaccine
efficacy as well as immune-mediated diseases and their patho-
logical features (1, 2). Circulating Abs are produced and secreted
by plasma cells after B cell activation, proliferation, and differ-
entiation (2, 3). In addition to a crucial impact of Ab concen-
trations, their functions are determined by affinity and the IgH
class or isotype, in addition to the exact epitope recognized (4).
Thus, the Fc region for IgE initiates classical complement fixation
very inefficiently compared with several IgG isotypes. Notwith-
standing differences between mice and humans, IgE is a key
mediator of allergic diseases and protection against extracellular
parasites, functions mediated by specific binding to FcεR1, a
class-specific high-affinity receptor present on mast cells and
basophils (5, 6). IgA also fails to initiate classical complement
fixation (7) but is crucial for managing host–microbe interactions
at mucosal surfaces, such as the airways and gut (8). Moreover,
FcRs for these Ig classes differ in their downstream effects and
species-specific expression (9). Thus, molecular mechanisms that
adjust the levels of different classes of Ig and the balance among
them are important aspects of immunity.
In the primary Ab response, activation of naive IgM/IgD-
expressing B cells leads to a variety of potential fates, the prob-
ability of each of which is dictated by the locale or trafficking of the
B lymphoblast and interactions with helper CD4+ T cells and the
cytokines they produce (10, 11). B cells that receive cognate T cell
help can enter the germinal center reaction and, if they survive
affinity selection, are better able to differentiate into memory
B cells or progress to become long-lived Ab-secreting plasma
cells (10–12). When the cytokine IL-4 predominates, B cells
switch their Ag-specific VH segment to the IgH Cε region, ei-
ther directly from Cm or as a secondary gene rearrangement from
the IgH Cg1 segment (13, 14). The ontogeny of cellular identity
and gene regulation within the Th cell population are fluid, but
CD4+ T cells are the predominant source of IL-4 to promote class
switching to IgE under physiological conditions (13, 15). To
provide this cytokine, Ag-activated T cells adopt gene expression
programs of Th2, IL-4–producing T follicular helper (TFH), or
Th2-derived T follicular helper phenotypes (16, 17). A variety of
signaling combinations can induce IL-4–producing Th2 or Th2-
derived T follicular helper cells, but these processes are potenti-
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ated or amplified by IL-4 and its induction of the transcription
factor STAT6 (18, 19). In addition to this B cell–extrinsic impact
of STAT6, IL-4 and STAT6 are required for B cell–intrinsic
aspects of class switching to IgE and, to a lesser extent, to IgG1
(20–22).
The regulators of class switching to IgA are more complex, as
a number of factors have been elucidated (23). The most important
soluble regulators of IgA production include TGF-b, retinoic acid
(RA), and the type 2 cytokine IL-5 (23, 24). Cell trafficking to gut
and other mucosal sites are major factors, so that the intestinal
tract and its associated lymphoid tissues are major sites for
IgA generation (25), but prominent drivers of IgA production
(i.e., TGF-b and RA) are not Th subset–specific products (23, 26).
However, one subset of dendritic cells (DCs), the CD103+ DC
population, is the major source of RA implicated in generation of
IgA+ B cells, whereas the TGF-b–rich environment promotes an
environment highly enriched for IL-17– and IL-22–producing
Th17 cells (27, 28). Strikingly, recent work indicates that Th17
cells drive IgA production (29). Nonetheless, IL-4 has the capacity
to enhance the generation of IgA+ B cells when combined with
primary regulators (30, 31). More broadly, the discovery of a Th2
phenotype identified a capacity of this T cell subset to promote Ab
responses (32, 33), and recent work involving TFH cells showed
dramatic decreases in Ab-secreting cells (ASCs) located in the
marrow in models of Ag-specific immunity when IL-4 or its re-
ceptor was absent (17).
Recall Ab responses in turn draw on the formation of Ag-specific
memory B cells from either IgM+ or isotype-switched B lym-
phoblasts after primary immune exposure (2). In parallel, the pool
of circulating Ab can be sustained by an alternative fate in which
plasmablasts become long-lived plasma cells that constitutively
secrete Ab for extended periods. Memory subsets arise most ef-
ficiently after T cell help and an effective germinal center reaction
(2, 3) involving B cells that survive BCR selection for survival but
do not become plasma cells (10). Long-lived plasma cells are vital
for steady-state production of Ag-specific Ab that may neutralize
a pathogen after re-exposure, but these cells and the circulating
Ab they produce decline over time, albeit at different rates for
Ab isotypes and different forms of immunogen (10). Thus, the
memory B cell pool can provide a vital back-up mechanism
whereby recall Ag stimulates renewed B cell activation, differ-
entiation into plasma cells, and increased circulating Ab. Although
this recall stimulation commonly requires renewed T cell help,
the molecules and mechanisms that influence the strength of recall
Ab responses need elucidation.
As noted above, IL-4 and STAT6 regulate both B cell–extrinsic
regulation of Ab responses via Th cell function and B cell–in-
trinsic processes. STAT6 heterodimers act as DNA binding pro-
teins that recruit transcriptional cofactors to a unique palindromic
element (18), but little is known about specific cofactors in Ab
responses. Poly-(ADP-ribose) polymerase (PARP) 14, a novel
STAT6-interacting protein with transcriptional cofactor function,
is in a superfamily of proteins with domains similar to those of
bacterial toxins that transfer ADP-ribose from NAD+ onto target
proteins (34). Initial analyses revealed that PARP14 increased
mRNA levels for a subset of STAT6-regulated genes in B cells and
enhanced survival signaling initiated by IL-4 treatment of B (but
not T) lymphocytes in vitro (35). Subsequent work showed that
PARP14 facilitates lymphomagenesis driven by persistent over-
expression of the oncogene c-Myc, is vital for a Myc-imposed
block at the pre-B stage of B lymphoid development, and helps
to transduce an IL-4 signal that promotes metabolic fitness and
survival of mature B cells (36). Furthermore, recent findings in-
dicate that c-Myc is a major regulator of germinal center B cells
and show an impact of PARP14 on survival of plasmacytoma cells
(37–39). However, to what extent the defects observed in the
absence of PARP14 impair Ab responses post infection or affect
recall responses is not clear. In the current study, we have analyzed
the contributions of PARP14 to primary and recall Ab responses
in disease models of infection with a common respiratory pathogen
and of allergic lung inflammation. Surprisingly, Ag-specific IgA
production and IgE production were both impaired, whereas that
of IgG1 was not, but analyses of the cellular basis for IgA and
IgE defects revealed both B cell–dependent and –independent
mechanisms along with a defect in potency of Th cell effectors.
Further, the results provide insight into an unexpected parallel
between functions of microbial ADP-ribosylating toxins and an
intracellular mammalian ADP-ribosyltransferase, and have impor-
tant implications in relation to potential new avenues for pharma-
cological intervention in immunity.
Materials and Methods
Mice and B cell transfer model
All mice [C57BL/6 (JAX; The Jackson Laboratory, Bar Harbor, ME), B6-
Rag22/2, B6-Parp142/2 mice, B6-OT-II TCR transgenic, and B6/129-
intercrossed Stat62/2] were housed in ventilated microisolators under
specified pathogen–free conditions in a Vanderbilt University mouse
facility and used at 6–8 wk of age following approved protocols. For
adoptive transfer experiments to measure Ab responses, T cells were de-
pleted using biotinylated anti-Thy1.2 Ab followed by streptavidin-
conjugated microbeads (iMag; BD Biosciences, San Jose, CA). Pooled
wild-type (WT) CD4+ T cells and OT-II CD4+ T cells (4 and 1 3 106 cells
per recipient, respectively) purified by positive selection with L3T4 anti-
CD4 microbeads (40) were mixed with pools of WT or Parp142/2 B cells
(5 3 106 cells per recipient) and injected i.v. into Rag22/2 recipients.
Reagents
Cytokines and mAbs (purified, biotinylated, or fluorophore conjugated)
were from BD Pharmingen unless otherwise indicated. 4-Hydroxy-3-
nitrophenylacetyl (NP)– and 4-hydroxy-3-iodo-5-nitrophenylacetyl (NIP)–
conjugated serum albumins (for capture ELISA) and carrier proteins
[keyhole limpet hemocyanin (KLH); OVA] were obtained from Biosearch
(Novato, CA). All-trans RA, DNase I, chicken OVA (41), LPS (42), and
collagenase (Clostridium histolyticum type VIII) were from Sigma-Aldrich
Chemicals (St. Louis, MO). IL-4 and IL-5 were obtained from Leinco
Technologies (St. Louis, MO), and TGF-b and BAFF were from R&D
Systems (Minneapolis, MN).
Infections, immunizations, and measurements of Ab responses
After collection of preimmune sera, mice were immunized with NP25-KLH
(100 mg i.p.) in alum (Imject; Thermo Scientific, Rockford IL), as de-
scribed (41). Primary immune sera were collected after 2 wk, followed by
preboost serum collection, an identical recall immunization 5 wk there-
after, and harvest 1 wk later for analyses. To immunize and rechallenge in
the context of primary and recall allergic lung inflammation, mice were
sensitized with OVA (20 mg per mouse) in alum (41) on days 0 and 7,
followed after 14 d by intranasal (i.n.) OVA (50 ml OVA, 10% w/v in
buffered saline) instillations on each of 4 consecutive days. For recall IgE
responses and allergic lung inflammation, mice (primary Ag inhalations 7
wk previously) were harvested the day after ending i.n. OVA rechallenges
(exactly as for primary responses) on each of 4 consecutive days. Bron-
choalveolar lavage (BAL) fluid sampling and counting of airway cell
populations were conducted as described (41). Cytokine levels in BAL
fluid were measured by the Milliplex Mouse Cytokine/Chemokine Lumi-
nex Kit (32-plex) (EMD-Millipore, Billerica, MA) according to the man-
ufacturer’s instructions. Lung inflammation and airway mucus were
determined based on H&E- and periodic acid–Schiff (PAS)–stained,
paraffin-embedded lung sections. Airway mucus was measured by a pa-
thologist blind to sample identity, using a semiquantitative grading system
based on the fraction of PAS+ airway epithelial cells [grade 0, no PAS
staining; grade 1, , 20%; grade 1.5, 21–40%; grade 2, 41–60%; grade 2.5,
61–80%; grade 3, . 81%]. For infectious challenges, mice were infected
with human metapneumovirus (hMPV) (1.5 3 106 PFU by i.n. instillation
under anesthesia) with a clinical isolate strain, as described (43), followed
by collection of primary immune sera after 3 wk. At 14 wk post infection,
mice were rechallenged in an identical manner and harvested 1 wk later for
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analyses. After first establishing dilutions at which absorbance values
would be in the linear range of the assay, isotype-specific relative levels of
Ag-specific Ab were quantitated by ELISA using plate-bound Ag ([NP-
BSA or PSA, OVA, or purified, recombinant hMPV F protein (44)] fol-
lowed by the series of isotype-specific second Ab of the SBA Clonotyping
System (Southern Biotech, Birmingham, AL), as described (41). Data for
Ag-specific Ab are shown after subtraction of low OD values from pre-
immune controls analyzed together with the immune sera and were sep-
arately determined to match values yielded by titration. ASCs were
analyzed by ELISPOT, as previously described (41), and quantitated using
an ImmunoSpot Analyzer (Cellular Technology, Shaker Heights, OH).
In vitro B cell cultures for class-switched Ab production
Splenic B cells were purified (90–95%) using biotinylated anti-CD19
mAb followed by streptavidin-conjugated microbeads, as above. For IgA,
B cells (106 cells in 1 ml) were activated with LPS (1 mg/ml) and cultured
with BAFF (10 ng/ml), TGF-b (5 ng/ml), IL-4 (10 ng/ml), IL-5 (10 ng/ml),
and all-trans RA (10 nM) in 10% FBS-supplemented medium exactly as
described (24). Surface IgA was analyzed by flow cytometry, with cells
harvested at 5 d, and culture supernatants were then harvested after 7 d to
measure IgA in the culture supernatants. For IgE, B cells (106 cells in 2 ml)
were activated with anti-CD40 (1 mg/ml; clone 3/23) (45) and cultured with
BAFF, IL-4, and IL-5 as for IgA analyses, followed by determination of
intracellular IgE by flow cytometry and ELISA to measure secreted IgE, as
described previously (46).
CD103+ DC analysis
Mononuclear cells of the mesenteric lymph nodes (MLNs), Peyer’s patches,
intestinal lamina propria (LP), and intraepithelial compartments (IECs)
were prepared from WT and Parp142/2 mice, as described (47). In brief,
small intestines were flushed with FBS 10% in Ca2+/Mg2+-free solution
(HBSS supplemented with HEPES and NaHCO3, pH 7.2) followed by
removal of Peyer’s patches. Intestinal segments were then incised
lengthwise, minced into 10% FBS in Ca2+/Mg2+-free solution with 0.1 mM
EDTA after mechanical removal of their mucus layers, shaken (45 min;
37˚C), and passed through a 70-mm aperture strainer. IECs were collected
from these eluates at the interface of 40–70% Percoll step gradients. The
remaining tissue was then digested in 5% FBS in HBSS containing col-
lagenase (1.5 mg/ml) and DNase1 (50 U/ml), and LP cells were collected
as the cells at the interface after the resulting cell suspensions were frac-
tionated on 40–70% Percoll step gradients. After counting, populations
were analyzed by flow cytometry, or RNA was extracted for analysis.
Mutagenesis and (ADP-ribosyl)transferase activity assay
ADP-ribosyltransferase dead mutants of PARP14 and PARP14(M-C) were
generated in pcDNA3 and the retrovector MiT by introductions of point
mutations into the C-terminal catalytic domain using Pfu polymerase; the
mutations and nonmutated complete sequence of each construct were
verified by DNA sequencing. Lysates of FNX cells transfected with WT or
triple-mutated constructs of pcDNA3-FLAG-PARP14 or pcDNA3-FLAG-
PARP14-MC were used for immunoprecipitations with monoclonal anti-
FLAG (M2) (Sigma-Aldrich). The resulting immune complexes, collected
using protein G beads (Santa Cruz Biotechnology, Santa Cruz, CA), were
rinsed and divided equally. Eluted proteins from one portion were analyzed
by immunoblotting, visualized, and quantitated using an Odyssey imaging
system (Li-Cor, Lincoln, NE) as described (40), whereas ADP-ribosyl
transferase activity in the other fraction was assayed as described (35),
with resolution on SDS-PAGE followed by autoradiography, and quantified
by Phosphor-Imaging. The specific activities of each construct were esti-
mated by normalization of the [32P]-automodified protein signal to the
steady-state expression level quantified by immunoblotting.
Th cell differentiation and retrovector transduction
Naive CD4+ T cells purified (95%) using anti-CD4 magnetic microbeads
(Miltenyi Biotec, Auburn, CA) and activated with plate-bound anti-CD3
plus soluble anti-CD28 (2.5 mg/ml each) were cultured in Th cell subset
differentiating conditions [Th1, anti–IL-4 (5 mg/ml) and IL-12 (10 ng/ml);
Th2, anti–IL-12 (3 mg/ml), anti–IFN-g (3 mg/ml), and IL-4 (10 ng/ml);
Th17, TGF-b (5 ng/ml), IL-6 (10 ng/ml), TNF-a (10 ng/ml), IL-1b (5 ng/
ml), IL-23 (10 ng/ml), anti–IL-4 (5 mg/ml), and anti–IFN-g (3 mg/ml)] as
described (40). MiT retrovector constructs were transfected into FNX
ecotropic packaging cells, whose supernatant media were then used for
“spinfection” of activated CD4+ T cells, as described (40). For retroviral
transduction to test Th17 differentiation capacity, activated T cells were
initially cultured in ThNull conditions [anti–IL-4 (5 mg/ml), anti–IL-12
(3 mg/ml), anti–IFN-g (3 mg/ml)] to block differentiation. For quantitation
of mRNA levels, RNAwas isolated after 5 d culture, and measurements of
differentiation and cytokine production were performed after secondary
stimulation, using intracellular cytokine staining and culture supernatants
of T cells, respectively. Cells were restimulated with plate-bound anti-CD3
and soluble anti-CD28 (0.5 mg/ml each), and either stained for intracellular
IFN-g, IL-4, and IL-17, along with surface CD4, as described (40), or
cultured without monensin. Cytokine concentrations in culture super-
natants were measured using a multiplex Th1/2/17 Cytokine Bead
Array (BD Pharmingen).
Measurements of RNA
RNAwas isolated using TRIzol reagent (Invitrogen). After cDNA synthesis
by reverse transcription, expression of genes was analyzed in duplicate
samples using SYBR Green PCR Master Mix (QIAGEN, Valencia, CA) by
quantitative real-time RT-PCR (qRT2, Supplemental Table I. Data are
presented as values normalized to WT control and averaged over PCR)
normalized to levels of hypoxanthine phosphoribosyltransferase (HPRT) as
internal control. Primer pairs are detailed in three independent biological
replicates.
Statistical analyses
The primary analyses comparing values for WT and Parp142/2 samples
were conducted as a two-tailed Student t test with posttest validation of its
suitability. The analyses consisted of separate pairwise determinations, but
2-way ANOVAwas also conducted across aggregate IgA and IgE responses,
to deal with potential concern about multiple testing. Data are expressed as
mean (6SEM), and results were considered statistically significant when the
p value for the null hypothesis for a comparison was , 0.05.
Results
Role for PARP14 in Ag-specific IgA responses
Previous work identified a STAT6-interacting transcriptional
coactivator, PARP14, and showed it to be an intracellular ADP-
ribosyltransferase. Surprisingly, later investigation uncovered an
apparently selective defect in survival and glycolytic fitness of
B cells from Parp142/2 mice and a need for PARP14 in facili-
tating certain actions of c-Myc (36), which is vital for sustaining
fully robust germinal center reactions (38, 39). Accordingly, we
hypothesized that PARP14 would affect Ab responses, particularly
those of higher affinities and the classes whose IgH constant
regions are most distant from IgH Cm. Because of the utility of
hapten-conjugate systems in dissection of Ab response mecha-
nisms, we first tested primary and recall Ab responses after
immunizations of WT and Parp142/2 mice with NP-KLH (48).
The primary and recall Ab levels for total Ig, IgM, and IgG1
(which dominate the total Ig pool) did not consistently differ be-
tween Parp142/2 mice and controls (Supplemental Fig. 1A, 1B).
However, recall responses of IgA (and, to a more modest extent,
those of IgG2a and IgG2b) were substantially lower in the absence
of PARP14 (Fig. 1; Supplemental Fig. 1C, 1D). In addition to
a decrease in anti-NP IgA in the early primary response (Fig. 1B),
the relative impairment of mice lacking PARP14 was worse after
recall immunization at 7 wk than at the earlier time (Fig. 1B, 1C,
Supplemental Fig. 1G). The germinal center reaction promotes a
heteroclitic response that generates NIP-reactive Ab after NP
immunization (48), and affinity maturation of the Ab repertoire
(12). Levels of NIP-reactive IgA and high-affinity (NP2-binding)
IgA in recall immune sera were also lower in Parp142/2 mice
compared with controls (Fig. 1C). Moreover, the serum levels of
total IgA, independent of Ag, were lower in the PARP14-deficient
mice than WT controls (Supplemental Fig. 1E). To determine if
PARP14 influences the generation of IgA reactive against a path-
ogen that infects mice by a mucosal route, we used a human
metapneumovirus (hMPV) infection model (Fig. 1D). As with
immunization (Ag in alum), Parp142/2 mice generated lower
levels of virus-specific serum IgA in the early primary response (at
peak infection) and the gap between WT and PARP14-deficient
mice was widened for IgA–anti-MPV in memory responses eli-
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cited by virus rechallenge [Fig. 1E; mean increases of recall over
primary IgA levels in Parp142/2 sera (0.114) were one-third those
of WT controls (0.377), p = 0.03]. A similar pattern, matching that
with NP-KLH, was also observed for IgG2a (Supplemental Fig.
1F). Moreover, fewer anti-MPV IgA-secreting cells were detected
in infected lungs of the PARP14-null animals (Fig. 1F). Together,
these results demonstrate that PARP14 plays a crucial role in
promoting IgA production.
B cell–extrinsic role of PARP14 in IgA regulation
Recent findings suggest that the Th17 subset and the prevalence of
CD103+ DCs are major determinants of the magnitude of an IgA
response (26, 28, 29). To dissect the mechanism of how PARP14
regulates IgA generation, we first investigated whether the
mechanism was predominantly intrinsic or extrinsic to B lineage
cells. WT CD4+ T cells were mixed with WT or Parp142/2
B cells and transferred into Rag22/2 mice that were then immu-
nized to score primary and recall Ab responses (Fig. 2A). Serum
anti-NP IgA levels and numbers of NP-specific IgA-secreting cells
were comparable in recipient mice that received Parp142/2 B cell
transfers, compared with controls (Fig. 2B). These results provide
evidence that a B cell–extrinsic defect led to impaired IgA pro-
duction in Parp142/2 mice. TGF-b and RA substantially induce
IgA in vitro (49), which is also promoted by IL-5 (49) and IL-4
(49). Preliminary tests indicated that a combination of all these
inducers (TGFb, RA, IL-4, and IL-5) yielded maximum fractions
of surface IgA+ B cells and levels of secreted IgA in the medium
(data not shown). The frequencies of membrane IgA+ B cells (Fig.
2C) and amounts of secreted IgA (Fig. 2D) were equivalent when
purified B cells from Parp142/2 and WT controls were then ac-
tivated and cultured under these (Fig. 2C, 2D) and other (data not
shown) conditions. Together, these results suggested that the in-
trinsic capacities to switch to the distal IgH C region gene segment
Ca and to yield IgA production are intact in Parp142/2 B lineage
cells, thereby implicating a B cell–extrinsic defect.
Impact of PARP14 on B cell–extrinsic regulators of IgA
Th cells directly and indirectly regulate most steps of the Ag-
specific response and B lineage memory. Th17 cells are particu-
larly prevalent at intestinal mucosal sites, and, along with CD103+
DCs, strongly promote the IgA fate for B lineage cells (29).
Moreover, IL-17–deficient mice have impaired IgA physiology,
suggesting a role for Th17 cells in IgA generation. When we
tested Th cell development in vitro, PARP14-deficient CD4+
T cells were altered in their Th17 potential. Thus, WT CD4+
T cells yielded high frequencies of IL-17+ cells, whereas this was
reduced by half for Parp142/2 CD4+ T cells (Fig. 3A, Table I).
Consistent with these results, IL-17 secretion by Parp142/2 Th17
cells was also decreased (Fig. 3B). Because PARP14 functions as
a cofactor for a subset of STAT6-dependent functions of IL-4, we
tested whether this unexpected effect of PARP14 on Th17 cell
differentiation affected other Th cell subsets. This analysis indi-
cated that Th2 production of IL-4 by Parp142/2 CD4+ T cells
was impaired (Fig. 3B), along with a trend toward diminished
IFN-g secretion and lower frequencies of Th1 cells (Fig. 3, Table
I). Transcription factors vital for Th17 differentiation and cyto-
kine production include RORgt, RORa, and, downstream from
TGF-b receptor signaling, Runx1 (50, 51). WT Th17 cells
expressed high levels of mRNA encoding RORa, RORgt, Smad3,
and Runx1. Although the level of Rorc was only marginally at-
tenuated in PARP14-null samples of developing Th17 cells, ex-
pression of Rora, Smad3, and Runx1 was substantially reduced in
Parp142/2 Th17 cells compared with WT controls, as were
mRNA levels for IL-17A and IL-22 (Fig. 3C). Thus, we conclude
that PARP14 affects components of the TGF-b response system
and transcription factors that regulate the Th17 phenotype as well
as Th17 differentiation and cytokine production.
CD103+ DCs are major cellular sources of RA and promote both
Th17 and IgA production, especially under conditions of inflam-
mation (26, 28, 52). On the basis of evidence that PARP14 acts by
a B lineage–extrinsic mechanism to promote IgA responses, we
measured CD103+ DCs in Parp142/2mice. CD103+ DCs in MLN,
IEC, and intestinal LP of Parp142/2 mice were reduced compared
with WT controls (Fig. 4A, 4B). A major mechanism by which
CD103+ DCs regulate IgA is through local enzymatic conversion of
vitamin A into RA via retinol aldehyde dehydrogenase (RALDH)
in these cells (28). Aldh1a2 encodes RALDH2, the principal iso-
FIGURE 1. PARP14 promotes recall IgA production. (A) Schedule of
immunizations for testing anti-hapten Ab responses. After collecting
preimmune samples, sera from WT and Parp142/2 mice (6 wk; n = 14
each) immunized with NP25-KLH in alum and subjected to recall chal-
lenge at 7 wk post immunization were sampled as indicated. (B and C)
Levels of IgA specific for Ag (NP24-BSA), of related specificity (NIP25-
BSA), or of high affinity (NP2-PSA) were measured using capture
ELISA, as described in Materials and Methods. Bar graphs show mean
(6SEM) OD450nm from measurements at 1:200 (B) and 1:50 (C) dilutions
of these sera in measurements validated by determinations of relative
concentrations by titration (Supplemental Fig. 1G). (D–F) PARP14
mediates antiviral IgA production post infection. (D) Schedule of human
hMPV infection and rechallenge. WT and Parp142/2 mice were infected
with hMPV, maintained for 12 wk after virus clearance (7–10 d), and then
rechallenged. Sera for measurements of antiviral Ab were collected as
indicated. (E) hMPV-specific IgA levels in primary and recall immune
sera (1:400 dilutions) were determined using purified recombinant hMPV
F (surface fusion) protein. (F) hMPV F-specific IgA-secreting cells in
lung were analyzed by ELISPOT assay, as described in Materials and
Methods.
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form of RALDH in IgA regulation, and Aldh1a2 mRNA levels in
the LP and IEC were lower in samples of PARP14-deficient mice
compared with WT controls (Fig. 4C). Moreover, mRNA for the
other two isoforms of RALDH, RALDH1 (Aldh1a1) and RALDH3
(Aldh1a3), were also lower in these Parp142/2 tissues (Fig. 4C).
These findings indicate that the B lineage–extrinsic defect involves
both the Th cell subset and the major source of RA, each of which is
critical for directing IgA production.
FIGURE 2. B cell–extrinsic role of PARP14 in IgA
production. (A) Schema of the adoptive transfer model.
B cells from WT or Parp142/2 mice were mixed with
WT CD4+ T cells (a 4:1 mixture of CD4+ T cells of B6
and OT-II mice), transferred into syngeneic Rag22/2
recipients, immunized with NP-OVA at the indicated
times, and harvested 1 wk after recall immunization.
(B) Shown are mean (6 SEM) OD450nm of Ag-specific
IgA levels in primary and recall immune sera (1:200
dilutions) (left panel) as well as frequencies of Ag-
specific IgA-secreting cells in bone marrow and spleen
(right panel) after recall challenge of adoptive transfer
mice (two biologically independent replicate experi-
ments comprising 8 mice of each genotype). (C and D)
After determination of conditions for maximal IgA
production, B cells from WT and Parp142/2 mice were
activated with LPS and cultured in the presence of
BAFF with IFN-g (to estimate precommitted B cells)
or TGF-b, RA, IL-4, and IL-5 for 5 d. Frequencies of
surface IgA+ cells among B220+-gated cells (C) and
secreted IgA in cultures (D) were measured. Bar graphs
show mean (6SEM) values from three independent
experiments.
FIGURE 3. PARP14 and Th cell differentiation. (A
and B) Naive CD4+ T cells from WT and Parp142/2
mice were cultured under Th1, Th2, and Th17 differ-
entiating conditions for 5 d after activation with aCD3
and aCD28. Equal numbers of viable cells were then
restimulated (aCD3 and aCD28), and the indicated
cytokines were detected by intracellular staining (A)
and as secreted proteins in culture supernatants (B). Bar
graphs show mean (6SEM) cytokine concentrations
from replicates in four independent experiments. (C)
Naive CD4+ T cells from WT and Parp142/2 mice
were activated with aCD3 plus aCD28, cultured under
null (ThNULL), Th1, Th2, and Th17 conditions for 5 d.
Transcript levels were measured by quantitative real-
time RT-PCR normalized to HPRT signal in the sample
and then to the level in WT ThNULL cells (set as rela-
tive level of 1) of the particular experiment. Bar graphs
show mean (6 SEM) relative expression measured in
samples from four independent culture experiments.
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ADP ribosyltransferase activity of PARP14 is crucial for Th17
differentiation
The physiological impact of the endogenous mammalian ADP-
ribosyl monotransferases is as yet completely unknown. How-
ever, pertussis and cholera exotoxins, which function by ADP-
ribosylation inside mammalian target cells (53, 54), promote the
Th17 response, so we tested whether the enzymatic activity of
PARP14 is critical for its function in Th cell differentiation.
To eliminate PARP14 mammalian mono(ADP-ribosyl)transferase
(mART) activity, we generated three point mutations (PARP143mut;
H1698F, Y1730N, and E1810K) at the canonical PARP cata-
lytic triad of the PARP14 enzymatic domain (Fig. 5A). ADP-
ribosyltransferase activity assays with PARP143mut showed an
essentially complete loss of transferase activity (Fig. 5B). To test
whether the impact of PARP14 on Th17 differentiation involves
mART activity, we performed retroviral reconstitutions of CD4+
T cells. PARP14-MC, a truncated form of PARP14 containing the
middle (triple macro domains) and C terminus (mART catalytic
domain) regions, has catalytic activity and can be packaged into
retrovirus virions. Activated CD4+ T cells lacking PARP14 were
transduced with PARP14-MC, PARP14-MC3mut or empty vector
(MiT), cultured under Th17 conditions, and scored for differen-
tiation efficiency, compared with controls. These analyses showed
that although the enzymatic activity of PARP14-MC was ∼ 1/10th
that of full-length PARP14 protein (Fig. 5B), PARP14-MC trans-
duction into PARP14-deficient CD4+ T cells restored their efficiency
of Th17 differentiation to a normal level (Fig. 5C), indicating that
the defect in Th17 differentiation is reversible after T cell activation.
Strikingly, however, PARP14-MC3mut transduction into Parp142/2
CD4+ T cells was unable to restore normal frequencies of IL-17+
cells (Fig. 5C). We conclude that the ADP-ribosyltransferase ac-
tivity of PARP14 plays a cell-intrinsic role in Th17 differentiation.
PARP14 promotes recall IgE and allergic responses
In vitro analyses showed that CD4+ IL-4+ T (Th2) cells differ-
entiated less efficiently in the absence of PARP14, and the im-
munization studies revealed impaired recall Ab responses. These
findings prompted us to investigate the impact of PARP14 on
a type 2 immune response and IgE, using models of primary and
recall allergic lung inflammation (Fig. 6A). WT and Parp142/2
mice showed similar numbers of inflammatory cells in BAL fluid
after a primary response, but eosinophil numbers in the BAL of
Parp142/2 mice were substantially reduced in their allergic
memory response (Fig. 6B). Mucus secretion in lungs was also
lower in Parp142/2 mice after a recall challenge, compared with
WT mice (Fig. 6C). Consistent with the in vitro differentiation
analyses, IL-4 concentrations in BAL fluids were much lower in
Parp142/2 mice compared with WT mice after recall immuni-
zation with OVA, and IL-17 was also reduced (Fig. 6D). These
results indicate that even after primary immune challenge, PARP14
promotes allergic inflammation in the memory phase, and are
consistent with a role for PARP14 in CD4+ T cell differentiation
into IL-4– and IL-17–producing cells.
PARP14-mediated IgE generation is B cell–intrinsic function
T cell–derived IL-4 is essential for isotype switching to IgE, so we
also tested whether PARP14 influences IgE production in the al-
lergic lung inflammation model. Consistent with a role for PARP14
in efficient IgE generation, concentrations of IgE anti-OVA were
reduced in Parp142/2 mice after both primary and recall exposures
(Fig. 7A). Indeed, the quantitative deficit in IgE production in
Parp142/2 mice increased for the memory response (Fig. 7A,
Supplemental Fig. 1H). To test whether the cellular basis for the
defect in IgE response was the same as that we observed for IgA,
we analyzed cultures of purified B cells in which activated lym-
phoblasts were induced to class-switch to IgE and secrete Ab.
Analyses of Parp142/2 samples, with the B cells of Stat62/2 mice
as controls, yielded results opposite from those obtained for IgA, in
that frequencies of IgE+ cells were lower for PARP14-deficient
B cells compared with WT controls (Fig. 7B). Consistent with
the reduction in IgE+ B cells, secreted IgE also was impaired in
Parp142/2 B cells (Fig. 7C). As expected, the frequency of IgE+
cells and secreted IgE were also impaired in the Stat62/2 samples
(Fig. 7B, 7C), indicating that PARP14 contributes to IgE response
in a B cell–intrinsic mechanism along with the likely effect of
impaired IL-4 production by Th cells. Collectively, these findings
provide evidence that PARP14 promotes recall Ab responses using
distinct cellular mechanisms in Ig class–dependent manner.
Discussion
Many bacterial exotoxins execute mono-ADP-ribosylation of
mammalian proteins inside the target cell and serve as strong
Table I. Effect of PARP14 on Th cell cytokine level
Genotype/Cell Culture Th1 (IFN-g) Th2 (IL-4) Th17 (IL-17A)
WT 68.9 6 7.3a 35.7 6 4.5 23.9 6 1.7
Parp142/2 60.2 6 8.2b 26.6 6 5.5b 14.1 6 0.9b
aMean 6 SEM % cytokine+ cells measured in the CD4+ viable lymphocyte gates
in three independent biological replicate experiments measuring efficiency of Th cell
subset differentiation, as described in Materials and Methods.
bp , 0.05 for the null hypothesis that no difference exists between WT and
Parp142/2 samples, as determined by two-tailed Student t testing.
FIGURE 4. Reduced levels of RALDH and CD103+ DCs in guts of
Parp142/2 mice. (A and B) Frequencies of CD103+ DCs. Single-cell
suspensions of IEC, LP, and MLN were analyzed by flow cytometry, as
described in Materials and Methods. Shown are representative FACS
profiles in the CD11c+ CD11b2 gate (A) and a graph (B) of the mean
(6SEM) relative level of cells in three independent replicate analyses. (C)
Levels of mRNA encoded by the Aldh1a1, -2, and -3 genes (RALDH1–3)
were measured by quantitative real-time RT-PCR after preparation of total
RNA from IEC and LP suspensions. Bar graphs show mean (6SEM) ex-
pression (relative to HPRT in the sample) measured in four (IEC) or six
(LP) independent replicate preparations.
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stimuli of Th17 responses, in addition to acting as adjuvants (53,
54). Highly specific interactions between an exotoxin and a host
adapter protein that promotes targeting of the host’s intracellular
substrates and the presence of ADP-ribose binding domains in
other microbes suggest coevolutionary relationships that exploit
normal host cell physiology (55, 56). The range of intracellular
FIGURE 5. ART-dependent reversion of Th17 dif-
ferentiation of PARP14-deficient T cells. (A) Amino
acid sequence spanning the presumptive catalytic triad
of PARP14 catalytic C domain and the point-mutated
residues in PARP143mut (34). (B) Proteins from cells
transfected with FLAG epitope-tagged PARP-14,
PARP-143mut, PARP-14-MC, or PARP-14-MC3mut
were precipitated with anti-FLAG. One aliquot of
bead-bound immune complexes was assayed for
transfer of [32P]-labeled ADP-ribose from NAD+ onto
proteins, whereas the other part was used for immu-
noblotting to measure the relative amounts of purified
PARP14 in each sample. Shown are autoradiographs
(upper left panel) and immunoblots to determine pro-
tein levels (lower left panel) after resolution by SDS-
PAGE. Arrowheads mark the expected positions for
full-length PARP14 and PARP14-MC. Right panel,
Phosphor-Imager quantitations (in arbitrary units of
pixel density) of the radioactive signal for each band
normalized to the protein level determined from the
immunoblots. (C) PARP14 and its ADP-ribosyl-
transferase activity are required for optimal Th17
differentiation. CD4+ T cells were activated under
nondifferentiating conditions, transduced to express
PARP14-MC or -MC3mut, cultured (5 d) under Th17
cell differentiating conditions, restimulated, and ana-
lyzed by flow cytometry. Shown are representative
FACS profiles of IL-17A in the transduced (Thy1.1+)
CD4+ gate.
FIGURE 6. Attenuated recall responses and allergic
lung inflammation in the absence of PARP14. (A) For
primary responses, WT and Parp142/2 mice were
sensitized with OVA in alum followed by i.n. instilla-
tion of Ag on each of 4 consecutive days. Recall IgE
and allergic inflammation were elicited by four daily
i.n. instillations of Ag 7 wk after primary allergic ex-
perience. (B) Inflammatory cells in the BAL fluid (left,
primary responses; right, recall responses). (C) Airway
mucin analyzed in PAS-stained paraffin-embedded
lung sections. Bar graphs show mean (6SEM) of rel-
ative mucin levels measured in three independent re-
call experiments. (D) Levels of Th cell cytokines in the
BAL fluid after recall challenge with OVA or saline
(PBS). Bar graphs show mean (6SEM) cytokine
concentrations obtained in three independent experi-
ments (totaling 12 mice of each genotype).
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mARTs endogenous in mammalian cells (55–57) supports this
possibility. However, very little is known about the physiological
functions of any of the eukaryotic mARTs or of their catalytic
activity. Using a loss-of-function mouse model, we show in this
article that PARP14, a macro domain–containing mART, promotes
high-affinity and recall Ab responses of several, but not all, iso-
types, and provide evidence for distinct cellular mechanisms
leading to these effects for the two H chain constant regions most
distal from Cm, that is, IgA and IgE. In particular, although
PARP14 exerted B cell–intrinsic function(s) that impacted the
efficiency of generating IgE+ B cells and the amount of secreted
IgE, IgA regulation by PARP14 was predominantly B cell ex-
trinsic. The B lineage–extrinsic mechanism was consistent with
a relay in which PARP14 promotes the Th17 subset in an ADP-
ribosylation–dependent manner, increasing CD103+ DCs and
RALDH in the gut and thereby enhancing the production of RA
and IgA. Collectively, the findings show that PARP14 influences
the class distribution, affinity repertoire, and recall capacity of Ab
responses, and provide direct evidence of the requirement for
protein mono-ADP-ribosylation in Th cell differentiation.
We observed that PARP14 not only mediates the primary IgA
response but also more dramatically influences IgA production
after recall challenge. This highly abundant Ab isotype differs from
most Ig classes because boundary tissues direct a substantial
portion of the IgA production into trans-mucosal secretion. Ac-
cordingly, luminal microbes encounter IgA prior to any tissue
entry, and this class of Ab appears to be a major regulator of the
commensal population (58, 59). The diversity of ADP-ribosylating
bacterial exotoxins (e.g., cholera, diphtheria, and pertussis toxins)
that induce Th17 responses and IgA production may be a part of
the microbial strategy for managing the host niche (58, 59). More
broadly, IgA regulation may be divided between systemic and
a locally segregated enteric immunity (58). In the systemic com-
partment, marginal zone B (MZB) cells possess the potential to
generate more IgA in vitro than conventional follicular B cells
(60), and PARP14-deficient mice have a reduction (∼50%) in
MZB cells (35). Thus, the deficit of MZB in Parp142/2 mice
might contribute to the impact of PARP14 deficiency on IgA.
Recent studies of the enteric compartment used lineage tracking to
provide evidence that Th17-phenotype cells can morph into TFH-
phenotype cells and that Th17 differentiation can be essential for
promoting IgA production (29). To what extent this effect is due to
direct [TFH17–Peyer’s patch germinal center (GC) B cell] or in-
direct mechanisms or some combination thereof remains to be
determined. Nonetheless, the findings strongly support the inter-
pretation that the inefficient generation of Th17 cells from naive
Parp142/2 precursors is a vital part of a B cell–extrinsic mecha-
nism for decreased IgA production. A detailed understanding has
yet to be elaborated, but an analogous contribution of subset-
restricted cytokines to Th cell effects on the Ig class distribution
may be present for IFN-g–dependent IgG isotypes. Thus, although
the magnitudes of the effects were smaller than for IgA and Th17
cells, IgG2a and IgG2b concentrations were lower in recall im-
munity of Parp142/2 mice. We also found that in addition to
a CD4 T cell–intrinsic capacity of this mART to promote Th17
differentiation, enteric CD103+ DCs were reduced in Parp142/2
mice, which may contribute to the quantitatively greater effects on
IgA than other Ab classes. These DCs in turn are critical sources
of RA, a key driver of B cell switching to IgA (26) and of Th cell
differentiation (52). The quantitative balance between mucosal
and systemic rates of Ag-specific IgA production rarely is clear.
Altogether, though, we suggest that PARP14 promotes IgA by
a mechanism that includes enhancement of Th17 differentiation,
CD103+ DCs, and RALDH generation of RA, with each cell type
important for the efficient production of IgA.
We also found that Ag-specific IgE levels, Th2 and Th17
cytokines, as well as airway eosinophils were reduced in a recall
model of allergic lung inflammation. Recent work has provided
parallel evidence that PARP14 affects a primary immune response
leading to allergic lung inflammation and IgE anti-OVA (61).
Intriguingly, our data revealed no reduction in pulmonary in-
flammation after the primary exposure, yet upon recall challenge
major markers of Th2 inflammation (eosinophil recruitment; IL-4)
were halved. Because the same model allergen was used, this
disparity of results most likely was due to differences in priming
between the two studies. Notwithstanding this point, our results
indicate that PARP14 can influence the intensity of a recall re-
sponse under conditions in which the primary episode of inflam-
mation was unaffected in Parp142/2 mice. A striking feature of
IgE physiology is that, in contrast to other Ab classes, Cε-
switched B cells are impersistent in germinal center reactions,
associated with a limited capacity to form IgE+ memory B cells
and long-lived ASCs (14, 46). Thus, recall IgE responses start
from a lower baseline and exhibit major contributions of sec-
ondary switching to Cε from Cg1 (14). The penetrance of an ef-
fect of PARP14 only on recall IgE in our experiments suggests the
speculative possibility that, in vivo, the expression of this (ADP-
ribosyl)transferase (ART) may better facilitate sterile IgH Cε
FIGURE 7. Impaired Ag-specific IgE responses in Parp142/2 mice. (A)
Serum levels of OVA-specific IgE from the OVA-induced recall allergic lung
inflammation mice (Fig. 6A) were measured by capture ELISA. Bar graphs
show mean (6SEM) OD450nm from measurements at 1:200 dilutions of the
sera from all three independent experiments (totaling 12 mice of each geno-
type), in measurements validated by determinations of relative concentrations
by titration (Supplemental Fig. 1H). (B and C) Naive B cells from WT,
Parp142/2, and Stat62/2 mice were activated with aCD40 and cultured 5 d
in the indicated cytokines. Frequencies of intracellular IgE+ cells in B220+-
gated cells (B) and secreted IgE in culture medium (C) were measured.
Shown are (B) a result from one representative experiment and (C) bar graphs
with mean (6SEM) values obtained in three independent experiments.
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transcription in the setting of secondary switching or memory
B cells than primary or naive counterparts. Alternatively, although
preliminary in vitro analyses did not reveal increased Prdm1
mRNA or Blimp1 protein in Parp142/2 B cells, these character-
istics may be due to prematurely dominant expression of Blimp-1,
a master regulator of plasma cells suppressor of B cell identity
(45). In part, the defect of Th2 differentiation efficiency in vitro
suggests that part of the weaker memory response in the PARP14-
deficient mice is attributable to weaker Th2 differentiation in vivo.
However, another possibility is raised by work indicating that in
antihelminthic immunity, the strength of memory Th2 inflamma-
tion is sustained, at least in part, by a subset of B lymphocytes
(62). In this regard, it is notable that the absence of PARP14 im-
peded effects of c-Myc on B cell physiology (36), and that recent
findings highlight that this proto-oncogene is highly expressed in
GC B cells and essential for supporting a sustained GC reaction (38,
39). Thus, because aspects of B cell physiology are altered in the
absence of PARP14, an intriguing possibility is that the decrease in
IgE memory manifested in recall allergic inflammation is due, at
least in part, to impairment of Parp142/2 B cells.
A key finding of this study is that the capacity to reverse impaired
Th17 differentiation in Parp142/2 T cells required the protein’s
catalytic function, as there has previously not been any evidence
of such a requirement for intracellular mammalian mARTs in
normal cell physiology. The mammalian family of intracellular
proteins with a domain similar to the catalytic PARP moiety has
17 members, of which PARP1 was first identified and acts as
a processive polymerase (57). Several PARP proteins lack enzy-
matic activity, others have not been assessed, and the rest are ei-
ther polymerases (“true PARPs”) or likely mono-ARTs. A major
emphasis of research in this area has been on critical roles of poly-
(ADP-ribosyl)ation in DNA damage responses and cancer, an
exciting feature of which is the emergence of PARP inhibitors
with evidence of efficacy in clinical trials (63). Moreover, al-
though polymerase-independent as well as polymerase-dependent
functions of PARP1 have been reported (64, 65), the absence of
the protein alters several aspects of inflammatory responses (66).
In parallel, animal studies have used similar nicotinamide or
NAD+ analogs to show beneficial effects on models of inflam-
mation, such as inflammatory arthritis (67), Helicobacter-induced
gastric preneoplasia in IL-10–deficient mice (68), and allergic
airway inflammation (61, 66). However, there are no specific
inhibitors for PARP14 and virtually none for PARP1. Existing
PARP inhibitors are NAD+ analogs that bind to a portion of each
catalytic domain that is structurally similar among PARP family
members. Both empiric testing of inhibition by commercially
available compounds, and a recent biophysical analysis that
evaluated the small-molecule inhibitors for their ability to bind
various PARP family members, showed that essentially all PARP
inhibitors interacted similarly with the various PARPs, including
PARP14 (63). For instance, PJ-34 completely blocks PARP14 as
well as PARP1 and other PARPs activity (35). Inasmuch as
PARP14 can mediate processes on which PARP1 has no identi-
fiable impact (35), the findings in this study raise important
questions about inhibitor studies in vivo as well as analyses of
conventional PARPs capable of executing branching polymeriza-
tion. Thus, critical assessments of which PARP family member(s)
are affected by such inhibitors will be vital. Because the Th17
response is active in Helicobacter infection (69) and analyses of
Th cell differentiation of Parp12/2 and Parp22/2 lymphocytes
failed to yield a defect observed for PJ-34 inhibition, it may be
that PARP14 is the active target of PJ-34 therapy in the setting of
gastric inflammation and preneoplasia (68). Moreover, although
PJ-34 has been reported to inhibit Th2 differentiation in vitro, we
could observe this inhibitory effect only at concentrations causing
high levels of T cell death and, as noted, cell-free assays indicate
that PARP1 and PARP14 exhibit comparable inhibitory concen-
tration curves with PJ-34 (M. Wei, S.H. Cho, and M. Boothby,
unpublished observations). Conversely, transduction of the cata-
lytically inactive PARP14-MC into Parp142/2 CD4 T cells de-
veloping in Th2 conditions reversed the Th2 differentiation defect
(S.H. Cho and M. Boothby, unpublished observations). In sum, the
results suggest that PJ-34 affects Th2 cell differentiation pre-
dominantly by a PARP14-independent mechanism, and this pro-
tein’s ART activity may be dispensable for Th2 differentiation yet
a cell-intrinsic signal promoting Th17 function.
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